OppenheimerFunds’s NuVasive, Inc. NUVA Stock Holding History

OppenheimerFunds’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$257K	Sell	4,522 -121	-3%	-$6.43K	﹤0.01%	1617
2018 Q4	$230K	Sell	4,643 -983	-17%	-$59.1K	﹤0.01%	1681
2018 Q3	$400K	Sell	5,626 -104	-2%	-$6.62K	﹤0.01%	1532
2018 Q2	$299K	Sell	5,730 -873,839	-99%	-$45.8M	﹤0.01%	1637
2018 Q1	$45.9M	Sell	879,569 -174,322	-17%	-$8.84M	0.06%	337
2017 Q4	$61.6M	Sell	1,053,891 -124,830	-11%	-$7.08M	0.07%	276
2017 Q3	$65.4M	Sell	1,178,721 -129,403	-10%	-$8.56M	0.08%	262
2017 Q2	$101M	Buy	1,308,124 +97,125	+8%	+$7.26M	0.12%	193
2017 Q1	$90.4M	Buy	1,210,999 +433,506	+56%	+$31.5M	0.11%	202
2016 Q4	$52.4M	Buy	777,493 +78,180	+11%	+$5.04M	0.07%	299
2016 Q3	$46.6M	Buy	699,313 +283,511	+68%	+$18.1M	0.06%	345
2016 Q2	$24.8M	Buy	415,802 +109,197	+36%	+$5.9M	0.03%	499
2016 Q1	$14.9M	Sell	306,605 -98,918	-24%	-$4.49M	0.02%	643
2015 Q4	$21.9M	Buy	405,523 +236,063	+139%	+$12M	0.03%	545
2015 Q3	$8.17M	Buy	+169,460	New	+$8.76M	0.01%	756
2015 Q2	–	Sell	-158,410	Closed	-$7.29M	–	974
2015 Q1	$7.29M	Buy	+158,410	New	+$7.36M	0.01%	800

Other funds holding NUVA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

OppenheimerFunds's NUVA Position: Q1 2019 in Review

OppenheimerFunds reduced its NuVasive, Inc. (NUVA) stake by 2.6% in Q1 2019, selling an estimated $6.43K and leaving 4,522 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

OppenheimerFunds first reported a position in NUVA in Q1 2015 and has held it in 16 quarters since. The position peaked at $101M in Q2 2017. 255 funds tracked by Wall St. Rank hold NUVA as of Q1 2019.

OppenheimerFunds held 4,522 shares of NuVasive, Inc. worth $257K as of Q1 2019.
OppenheimerFunds sold 121 NuVasive, Inc. shares in Q1 2019, an estimated $6.43K.
NuVasive, Inc. made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1617 holding.
OppenheimerFunds first reported a position in NuVasive, Inc. in Q1 2015 and has held it in 16 quarters since.
OppenheimerFunds's NuVasive, Inc. position peaked at $101M in Q2 2017.
255 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.